Peptide Therapy Cost Guide: What to Budget for Each Protocol

Introduction

Peptide therapy pricing varies dramatically by peptide, access route, and clinical context. A research-grade vial of BPC-157 from an online vendor might run $40. A monthly supply of compounded semaglutide from a 503A pharmacy runs $200 to $400. Brand-name semaglutide as Wegovy® or Ozempic® without insurance is $1,000 or more per month. FDA-approved elamipretide as Forzinity for Barth syndrome runs into six figures per year.

These price gaps reflect more than the molecule cost. They reflect regulatory pathway, manufacturing standards, prescribing infrastructure, insurance coverage, and the underlying clinical evidence base. Understanding which costs you’re paying for, and which corners you might be cutting, matters for both safety and outcome.

This guide breaks down typical pricing for major peptide categories, the cost drivers behind those prices, and what to expect from each access route.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Drives Peptide Therapy Costs?

Several factors stack to determine the price you pay. The molecule itself, particularly for synthetic peptides, is often a small fraction of total cost. Manufacturing and quality control add layers, especially for products meeting USP, FDA, or international pharmacopeia standards.

Quick Answer: Compounded GLP-1 (semaglutide/tirzepatide) from 503A pharmacies typically $200 to $500 per month

Distribution and pharmacy markup add more. For physician-prescribed products, the clinic fee for evaluation, prescription, and monitoring is typically separate from the peptide cost. Insurance coverage, where it exists, can reduce out-of-pocket costs dramatically but is often denied for off-label or wellness use.

The regulatory pathway matters most. FDA-approved drugs go through the most expensive development and manufacturing process and price accordingly. Compounded peptides under section 503A skip the FDA approval cost but follow USP compounding standards. Research-grade peptides skip both, which is why they’re cheapest and also why they’re labeled not for human use.

GLP-1 Medications for Weight Loss

This is the largest category by patient volume. For semaglutide and tirzepatide, several pricing tiers exist.

Brand-name semaglutide as Wegovy (for weight loss) or Ozempic (for type 2 diabetes) runs $900 to $1,400 per month at full retail without insurance. Brand-name tirzepatide as Zepbound® (weight loss) or Mounjaro® (diabetes) runs similar. Manufacturer savings cards can reduce out-of-pocket costs for eligible patients, sometimes substantially.

Compounded semaglutide and tirzepatide from 503A pharmacies typically runs $200 to $500 per month. This was the dominant supply pathway during 2023 and 2024 when the brand drugs were on FDA shortage lists. Following the FDA’s October 2024 declaration that the shortage had resolved, the 503A compounding landscape changed, with continued availability through individual physician-pharmacy relationships under section 503A subject to evolving FDA guidance.

TrimRx is a telehealth platform offering compounded semaglutide and tirzepatide. The free assessment quiz determines if you qualify, and the personalized treatment plan structures your therapy. Pricing through TrimRx falls in the compounded peptide range, dramatically below brand-name retail.

The evidence base for GLP-1 medicines is enormous. STEP 1 (Wilding 2021 NEJM) showed 14.9% weight loss with semaglutide at 68 weeks. SURMOUNT-1 (Jastreboff 2022 NEJM) showed 20.9% with tirzepatide at 72 weeks. SELECT (Lincoff 2023 NEJM) showed 20% MACE reduction in patients with established cardiovascular disease and overweight or obesity.

Growth Hormone Secretagogue Peptides

CJC-1295 and ipamorelin, often stacked together, are among the most prescribed peptide protocols in wellness clinics. Compounding pharmacy pricing typically runs $200 to $400 per month for the stack at standard dosing of 100 to 300 mcg of each per day.

Clinic consultation and monitoring fees are usually separate, often $200 to $500 for initial evaluation and $100 to $300 for periodic follow-up. Lab work for IGF-1 monitoring runs $50 to $150 per draw depending on lab and insurance.

Tesamorelin (Egrifta), an FDA-approved GHRH analog for HIV-associated lipodystrophy, runs $3,000 to $4,000 per month at full retail. It’s used off-label in some wellness clinics for fat loss in non-HIV patients at out-of-pocket cost. Insurance coverage is generally limited to the labeled indication.

The 2023 FDA review of 503A compoundable peptides moved CJC-1295 and ipamorelin into more restricted status, narrowing access. Patients should expect availability to be variable across pharmacies.

Tissue Repair Peptides

BPC-157, TB-500 (thymosin beta 4), and GHK-Cu are the most commonly used tissue repair peptides. None are FDA-approved or 503A-compoundable as of 2026.

Research-grade BPC-157 from online vendors runs $20 to $60 per 5 mg vial. A typical month of use at 250 to 500 mcg daily uses one to two vials, putting monthly cost at $20 to $120 for research-grade material. These products are labeled not for human use and carry no quality assurance.

TB-500 research-grade pricing runs $40 to $100 per 5 mg vial. A typical month at 2 to 5 mg per week uses about two vials. Monthly cost at $80 to $200 for research-grade material.

GHK-Cu research-grade pricing varies by formulation, with topical preparations running $50 to $150 per month for cosmetic use. Injectable research-grade GHK-Cu runs similar pricing to other research peptides.

The evidence base for tissue repair peptides is largely animal studies and case reports. Reliable human RCTs are very limited. The clinical claims often outrun the data.

Sexual Function Peptides

PT-141 (bremelanotide) is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. List price for Vyleesi runs around $300 to $400 per pre-filled auto-injector. Used as labeled, monthly cost varies by use frequency.

Compounded PT-141 from 503A pharmacies historically ran $50 to $200 per month at typical use, though 2023 regulatory changes have affected availability. Some patients receive it through bremelanotide as the FDA-approved product instead.

Kisspeptin and other reproductive peptides aren’t commercially available outside research settings.

Cognitive and Brain Peptides

Selank, semax, and cerebrolysin are commonly mentioned in nootropic communities. None are FDA-approved or 503A-compoundable in the US.

Research-grade semax and selank from online vendors run $30 to $80 per vial, with monthly costs in the $30 to $150 range depending on dosing. Cerebrolysin imported from Eastern European pharmacies runs $50 to $150 per 10 mL ampoule, with full courses costing $500 to $2,000.

None of these are evidence-based cognitive enhancers in healthy adults. The Russian-language clinical literature on selank and semax is somewhat positive in specific clinical contexts (anxiety, post-stroke recovery), but Western replication is limited.

Key Takeaway: Compounded growth hormone peptide stacks $200 to $600 per month before clinic fees

Longevity and Senolytic Peptides

FOXO4-DRI, epithalon, thymalin, MOTS-c, and other longevity-positioned peptides are sold as research grade through online vendors. Pricing ranges widely.

FOXO4-DRI runs $200 to $800 per 5 to 25 mg from research vendors. Epithalon runs $30 to $100 per 10 mg vial. Thymalin imported from Russian pharmacies runs $50 to $200 per course. MOTS-c runs $50 to $200 per vial depending on source.

None of these have FDA approval or strong human clinical trial data for longevity outcomes. The evidence base for most is preclinical or small early-phase clinical work.

Immune Peptides

Thymosin alpha 1 (Zadaxin) is approved in many countries for hepatitis B and C and other indications, with international pricing of $200 to $500 per month at standard 1.6 mg twice-weekly dosing. US compounding pharmacy availability has narrowed since 2023 regulatory review.

Thymalin (Russian thymus extract) imported through gray channels runs $50 to $150 per course of 10 doses.

Cerebrolysin (covered above under cognitive peptides) is sometimes positioned in immune contexts as well.

What About Insurance Coverage?

For FDA-approved indications, insurance coverage varies. Brand-name semaglutide (Ozempic) and tirzepatide (Mounjaro) for type 2 diabetes are usually covered by commercial insurance with prior authorization. Brand-name semaglutide (Wegovy) and tirzepatide (Zepbound) for weight loss are covered less consistently, with many plans denying coverage even with documented BMI and comorbidities.

Medicare doesn’t cover weight loss drugs as a class, though there’s ongoing policy discussion about exceptions for patients with established cardiovascular disease following the SELECT results.

For off-label and wellness peptides, insurance coverage is essentially nonexistent. Patients pay out-of-pocket through compounding pharmacy or online vendor channels.

Where Do Gray-market Savings Go Wrong?

The cost gap between research-grade peptides and pharmacy-compounded or FDA-approved products is significant, often 5x to 10x. Some of that gap reflects regulatory overhead. Some of it reflects quality assurance and safety infrastructure that has real value.

Research-grade peptides from online vendors aren’t sterility-tested for injection. Identity and potency aren’t verified for individual lots. Endotoxin contamination has been documented in seized peptide samples. Self-administration without medical supervision skips the safety checkpoint of having someone monitor for side effects and unexpected reactions.

For peptides with serious mechanism of action (GLP-1 agonists, GH secretagogues, melanocortin agonists), the consequences of dosing errors, contaminated product, or unmonitored side effects can be significant. The savings often don’t justify the risk.

Building a Peptide Therapy Budget

For most patients, the rational approach is to focus spending on peptides with the strongest evidence base. For weight loss and cardiometabolic disease, that’s the GLP-1 class through a legitimate prescribing channel.

Compounded semaglutide or tirzepatide through a telehealth platform like TrimRx typically runs $200 to $500 per month including the medication and clinical supervision. Compared with brand-name retail at $900 to $1,400 per month, the savings are substantial while preserving quality and oversight.

For tissue repair, cognitive enhancement, or general longevity claims, the evidence base is weaker. Spending money on those peptides before maximizing evidence-based interventions (training, sleep, nutrition, validated medications) is putting money where the data isn’t.

The TrimRx free assessment quiz determines if compounded semaglutide or tirzepatide is appropriate for your situation. The personalized treatment plan structures therapy around your goals and clinical picture.

Bottom line: Insurance coverage varies dramatically; for GLP-1 weight loss, often denied; for type 2 diabetes, often covered

FAQ

Why Is Compounded Semaglutide So Much Cheaper Than Wegovy?

Compounded semaglutide skips the FDA approval and brand-name distribution markup. The peptide itself is similar to the brand product, but the regulatory pathway and pricing structure are different. Compounding requires a valid prescription and operates under section 503A.

Is Research-grade BPC-157 the Same as a Pharmacy Product?

The molecule may be similar, but there’s no FDA-approved or 503A-compoundable BPC-157 product. Research-grade material isn’t sterility-tested or identity-verified for human injection. Self-administration carries product quality risk.

Why Doesn’t Insurance Cover Peptide Therapy?

For off-label and wellness peptides, no insurance covers because the evidence base doesn’t meet medical necessity standards. For FDA-approved indications like GLP-1 in type 2 diabetes, coverage exists with prior authorization. For weight loss specifically, coverage varies by plan.

What’s the Cheapest Legitimate GLP-1 Option?

Compounded semaglutide or tirzepatide through a 503A pharmacy with telehealth prescribing typically runs $200 to $500 per month, the cheapest legitimate access route. Brand-name options can be cheaper with manufacturer savings cards if you qualify.

Should I Buy Peptides From Research Vendors to Save Money?

The cost savings are real, but you’re trading safety and quality assurance. For low-stakes topical use, the risk is lower. For systemic peptides with significant pharmacology, the risk profile changes. Sterility, identity, and supervision matter.

How Much Does a Typical Wellness Clinic Peptide Protocol Cost?

Including consultation, peptides, and monitoring, expect $300 to $1,500 per month depending on the protocol. Multi-peptide stacks at multiple clinics with regular labs run on the higher end.

Does Medicare Cover GLP-1 for Weight Loss?

Not currently, by statute. There’s ongoing policy discussion about exceptions for established cardiovascular disease following SELECT trial results, but as of 2026 Medicare doesn’t cover GLP-1 for weight loss as a class.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.